Gel was sold under eight different brand names.
If you use ultrasound gel regularly, you’ll want to pay attention to a recent recall from the U.S. Food & Drug Administration (FDA).
In an Aug. 4 announcement, the FDA recalled eight lots of Eco-Med Pharmaceuticals ultrasound gel, citing contamination.
As of publication time 15 patients have contracted confirmed bacterial infections from the Eco-Gel 200 ultrasound gel. Additional cases are suspected but have not been confirmed.
Eco-Gel advised its customers to immediately discontinue use of the product and return it, if possible.
“Eco-Med has initiated this recall and quarantine due to bacterial contamination in the affected lots of ultrasound gel with Burkholderia cepacia complex (Bcc),” officials said in the FDA notification. “The source(s) of the bacterial contamination is currently unknown. Eco-Med is conducting a comprehensive investigation to determine the root cause of this contamination and take all necessary corrective action.”
Affected patients can be asymptomatic, or they could develop a serious infection, such as bloodstream infections that can cause sepsis or death.
Eight Eco-Med lots have been recalled:
The lots were sold under these brand names in the United States:
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.